Also, our results suggest that the reduction in HIF-1α possibly is involved in the reduction in the thickening and remodeling of the pulmonary arteries, thus improving tissue oxygenation, reducing RV hypertrophy, and increasing survival in PAH. This evidence concerns the gene HIF1A and pulmonary arterial hypertension.